International law firm Greenberg Traurig, LLP congratulates its client, Avita Medical Ltd., on being awarded a contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) reported to be worth up to $53.9 million for late-stage clinical development and procurement of its ReCell® Autologous Cell Harvesting Device under a U.S. mass casualty preparedness program.

BOSTON, Mass. (PRWEB) October 12, 2015

International law firm Greenberg Traurig, LLP congratulates its client, Avita Medical Ltd., on being awarded a contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) reported to be worth up to $53.9 million for late-stage clinical development and procurement of its ReCell® Autologous Cell Harvesting Device under a U.S. mass casualty preparedness program.

The five-year contract commits a minimum of $16.9 million to support Avita’s ongoing U.S. clinical regulatory program towards FDA Premarket Approval (PMA) and to procure more than 5,000 ReCell® devices to establish an inventory so that ReCell® can be deployed to help deal with a mass casualty scenario involving burn injuries, according to the company. Additionally, they report that under the contract, Avita also has the potential to receive up to an additional $37 million if contract options are exercised which provide support for further clinical studies potentially required by the FDA as part of post-market surveillance, or as needed to expand the use of ReCell® to the pediatric population. Lastly, contract options provide the U.S. government with surge capacity, supplementing a national stockpile of ReCell® devices. Total procurement under the contract would cover more than 25,000 units of the ReCell® devices, according to Avita.

Greenberg Traurig Boston Intellectual Property (IP) attorney and Of Counsel, Fang Xie, Ph.D., helps Avita design, build and secure IP protection around the company’s ReCell® technology. Michael J. Schaengold, Shareholder and co-chair of the firm’s Government Contracts & Projects Practice in Washington, D.C., advised Avita on the BARDA contract.

advertisement | advertise on newsday

About Greenberg Traurig, LLP
Greenberg Traurig, LLP is an international, multi-practice law firm with approximately 1,900 attorneys serving clients from 38 offices in the United States, Latin America, Europe, Asia, and the Middle East. The firm is No. 1 on the 2015 Law360 Most Charitable Firms list, third largest in the U.S. on the 2015 Law360 400, on the 2015 Am Law Global 100, and among the 2015 BTI Brand Elite. More information at: http://www.gtlaw.com.

Contact: Lisa Murray | T: 617.835.0396 | E: lisa(at)murraywhalen(dot)com

For the original version on PRWeb visit: http://www.prweb.com/releases/2015/10/prweb13015323.htm